IBDEI0QH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13065,2)
 ;;=^66809
 ;;^UTILITY(U,$J,358.3,13066,0)
 ;;=705.81^^87^829^21
 ;;^UTILITY(U,$J,358.3,13066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13066,1,4,0)
 ;;=4^705.81
 ;;^UTILITY(U,$J,358.3,13066,1,5,0)
 ;;=5^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,13066,2)
 ;;=^96545
 ;;^UTILITY(U,$J,358.3,13067,0)
 ;;=695.9^^87^829^23
 ;;^UTILITY(U,$J,358.3,13067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13067,1,4,0)
 ;;=4^695.9
 ;;^UTILITY(U,$J,358.3,13067,1,5,0)
 ;;=5^Erythematous Condition
 ;;^UTILITY(U,$J,358.3,13067,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,13068,0)
 ;;=704.9^^87^829^25
 ;;^UTILITY(U,$J,358.3,13068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13068,1,4,0)
 ;;=4^704.9
 ;;^UTILITY(U,$J,358.3,13068,1,5,0)
 ;;=5^Hair Disease Nos
 ;;^UTILITY(U,$J,358.3,13068,2)
 ;;=^53658
 ;;^UTILITY(U,$J,358.3,13069,0)
 ;;=705.83^^87^829^26
 ;;^UTILITY(U,$J,358.3,13069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13069,1,4,0)
 ;;=4^705.83
 ;;^UTILITY(U,$J,358.3,13069,1,5,0)
 ;;=5^Hidradenitis
 ;;^UTILITY(U,$J,358.3,13069,2)
 ;;=^184621
 ;;^UTILITY(U,$J,358.3,13070,0)
 ;;=695.89^^87^829^30
 ;;^UTILITY(U,$J,358.3,13070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13070,1,4,0)
 ;;=4^695.89
 ;;^UTILITY(U,$J,358.3,13070,1,5,0)
 ;;=5^Intertrigo
 ;;^UTILITY(U,$J,358.3,13070,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,13071,0)
 ;;=703.0^^87^829^29
 ;;^UTILITY(U,$J,358.3,13071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13071,1,4,0)
 ;;=4^703.0
 ;;^UTILITY(U,$J,358.3,13071,1,5,0)
 ;;=5^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,13071,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,13072,0)
 ;;=692.72^^87^829^3
 ;;^UTILITY(U,$J,358.3,13072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13072,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,13072,1,5,0)
 ;;=5^Acute Solar Skin Damage
 ;;^UTILITY(U,$J,358.3,13072,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,13073,0)
 ;;=692.6^^87^829^32
 ;;^UTILITY(U,$J,358.3,13073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13073,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,13073,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,13073,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,13074,0)
 ;;=698.0^^87^829^40
 ;;^UTILITY(U,$J,358.3,13074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13074,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,13074,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,13074,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,13075,0)
 ;;=698.9^^87^829^39
 ;;^UTILITY(U,$J,358.3,13075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13075,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,13075,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,13075,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,13076,0)
 ;;=696.1^^87^829^41
 ;;^UTILITY(U,$J,358.3,13076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13076,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,13076,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,13076,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,13077,0)
 ;;=706.2^^87^829^44
 ;;^UTILITY(U,$J,358.3,13077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13077,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,13077,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,13077,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,13078,0)
 ;;=690.10^^87^829^47
 ;;^UTILITY(U,$J,358.3,13078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13078,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,13078,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,13078,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,13079,0)
 ;;=702.11^^87^829^45
 ;;^UTILITY(U,$J,358.3,13079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13079,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,13079,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
